Pharmafile Logo
Pharmafocus logo
Advanced Search

Department of Justice

Showing 7 posts of 7 posts found.

unnamed_1

US Department of Justice charges Teva with generic price fixing

August 26, 2020
Research and Development Department of Justice, Teva Pharmaceuticals

The US Department of Justice (DOJ) has charged Teva Pharmaceuticals with conspiracy to fix the price of its generic drugs. …

News
shutterstock_274590824

Ex-Pharmacy Compliance Director pleads guilty to introducing illegal drugs into the market

November 24, 2017
Medical Communications Department of Justice, FDA, pharma

Caprice Bearden, a 63-year old ex-Director of Compliance for an Indiana-based Pharmakon, has been found guilty of introducing adulterated drugs …

News

Mylan ducks call to testify in front of Senate

November 22, 2016
Manufacturing and Production, Medical Communications Department of Justice, Mylan, epipen

Mylan has avoided the call to testify in front of the Senate judiciary committee. The hearing will be convened under …

News
ABPI code

Regulation of drug promotion ‘should be toughened up’, study finds

January 29, 2016
Medical Communications ABPI Code, Department of Justice, PMCPA, Prescription Medicines Code of Practice Authority, Sunshine Act, marketing, off label, off-label, promotion

The voluntary code of conduct system that regulates the pharma industry’s promotion of off-label prescribing has a ‘limited capacity’ to …

News
Shire image

Shire accused of dishonest marketing in US

September 25, 2014
Medical Communications, Sales and Marketing Adderall XR, Department of Justice, DoJ, Shire, US, amphetamine, dextroamphetamine

Shire will pay a fine of $56.5 million to resolve a string of legal allegations in the US surrounding the …

News
Vioxx

Merck pays $950 million to settle Vioxx charges

November 23, 2011
Sales and Marketing Department of Justice, Merck, Vioxx, marketing violations, off label marketing

Merck will pay out $950 million and admit that it illegally marketed its painkiller Vioxx in the US. It will …

News

Gilead manufacturing under investigation by US authorities

June 14, 2011
Manufacturing and Production Department of Justice, Gilead, manufacturing compliance, pharma manufacturing

Gilead Sciences is being investigated by the US authorities over the manufacturing and distribution of some of its products, and …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026